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Fournier’s Gangrene is a rapidly progressive necrotizing fasciitis of the groin, perianal and perineal region
that is often polymicrobial in nature, often averaging 3 species of bacteria per patient. The typical
infection can be due to a host of microbes, including gram positive, gram negative and anaerobic species
including. Many of the causative organisms are found in the normal microbial ﬂora of the perineum.
Therefore, Fourniers is an opportunistic infection most commonly affecting the immunosuppressed. The
majority of Fournier’s gangrene are bacterial; however there have been cases of fungal Fournier’s
gangrene reported in the literature.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Fournier’s gangrene is often associated with polymicrobial
infection of those that are immunosuppressed.1e3 The following
case demonstrates that, in addition to antibiotics, antifungals
should be administered at the time of treatment.1
Case report
A 54 year old male admitted to University of Texas Medical
Branch for work up of newly diagnosed acute myeloid leukemia.
The patient’s past medical history was signiﬁcant for prostate
cancer, hepatitis C virus, non-insulin dependent diabetes mellitus,
and hypertension. After initiation of chemotherapy the patient was
diagnosed with neutropenic fevers and eventually developed
pneumonia, respiratory distress requiring intubation, and septic
shock. His blood cultures revealed Serratia marcescens. The patient
was treated in themedical intensive care unit with vancomycin, and
pipercillin-tazobactam. In addition, he was also on prophylactic
acyclovir and ﬂuconazole. During the patients intensive care
admission a condom catheter was placed for accurate output
measurements.
The patient was eventually extubated and the condom catheter
was removed. Upon removal of the condom catheter a penile pain
was noted and a lesion was seen. Urology was consulted on day 22
for evaluation of the patient’s genitals. Laboratory review at the
time of consultation were signiﬁcant for white blood cell count ofll@gmail.com (R. Roberts).
Inc. This is an open access article u<0.1 103/mcL, hemoglobin of 7.2 g/dL, platelet count of 42  103/
mcL, serum sodium levels of 130 mEq/L, glucose of 230 mg/dL, and
creatinine of 0.52 ng/dl.
A genitourinary exam revealed a blackened scrotum and a penile
shaft with crepitus and eschars consistent with Fournier’s
gangrene, however, there was no foul smell. The patient was
immediately taken for genitourinary debridement. During this
procedure the left testis was found to be grossly involved and
necrotic appearing, therefore a left orchiectomy and left hemi-
scrotectomy was performed.
Post-operatively the patient was stable and afebrile, however his
mental status was noted to be altered with episodes of confusion.
Quantitative analysis returned on post-operative day four positive
for the fungus zygomycetes, and patient was started on systemic
liposomal Amphotericin B. The patient’s wound was noted to be
mottled with a paucity of granulation tissue, therefore, the patient
was taken back to the operating room for a second debridement.
The second debridement included right orchiectomy, supra-
pubic tube placement, penectomy as well as further groin
debridement. The Burn team was consulted intra-operatively for
more aggressive debridement. Post-operatively the patient
received amphotericin soaked dressing changes, as well ampho-
tericin bladder irrigation. He underwent a third debridement with
the Burn team.
On post-operative day 16 the patient became hypotensive,
tachycardic, febrile; and a green growth was noted on the groin so
further debridement with the Burn team was scheduled. Before
further debridement was possible the patient’s conditionworsened
and the medical intensive care unit noted the patient’s demise on
post-operative day 18.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. After second debridement.
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Zygomycetes is ubiquitous and its spores are found in outdoor
and indoor air samples.1
Risk factors for hosting an infection include leukemia; neu-
tropenia due to chemotherapy; broad-spectrum antibiotics dis-
rupting normal ﬂora; diabetes mellitus; and steroid use due to their
ability to induce diabetes mellitus and decrease inﬂammatory
response 1. Once diagnosed, amphotericin B is the preferred anti-
fungal, but since it can impair renal function its use is sometimes
halted prematurely.1
Zygomycosis can occur as a cutaneous, subcutaneous, rhinoc-
erebral, pulmonary, or disseminated infection. The cutaneous form
of the zygomycetes can occur either by primary infection at the site
or by dissemination from another location in the host. Presentation
of the primary infection include red lesions which may develop to
black eschars and slough off to produce ulcers. The cutaneous form
of infection can delve deeper into the fat and fascia to become
necrotizing fasciitis. An infection that has progressed this far has a
high mortality rate, but once it has disseminated hematogenously
mortality rates can go even higher to between 94% and 100%.1,4
To further complicate the situation, Rhizopus, the genus
responsible for 90% of cases of zygomycosis,1 are characteristic for
angioinvasion, thrombosis and necrosis.1 This is particularly
dangerous in cases of Fournier’s gangrene due to the complicated
lymphatic system of the genital region (Figs. 1e3).Discussion
Early recognition of fungal genitourinary infection is of para-
mount importance as zygomycosis can quickly become dissemi-
nated and carries a high mortality rate. Our patient was particularly
susceptible to infection, possessing many of the risk factors asso-
ciated with zygomycosis infection.
This patients physical exam was unique for fungal Fourniers
upon ﬁrst encounter.
Firstly, the patient did not possess the fetid odor that usually
occurs as part of bacterial Fourniers gangrene. Secondly, the patient
had what appeared to be an infarcted testicle intra-operatively,Figure 1. After ﬁrst debridement.which does not occur in the context of bacterial Fournier’s
gangrene. These unique ﬁnding should have raised suspicion for
fungal infection. Thirdly, our patient was immunocompromised
from receiving chemotherapy, recent bacteremic, and intubated due
to respiratory distress secondary topneumonia.We should be aware
as clinicians that such patients are at high risk for fungal infections.
Once cultures returned positive for Rhizopus amphotericin B
was administered, but 4 days had already passed since the initialFigure 3. After second debridement e penectomy specimen.
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disseminated zygomycosis at presentation there was very little
possibility of rescuing the patient at onset. The aggressive nature of
zygomycetes infection necessitates an equally aggressive treatment
plan. Multiple debridements may be necessary with simultaneous
antifungal therapy but even this may not be sufﬁcient.Conﬂict of interest
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